Exploring the immune landscape of anal squamous cell carcinoma and the therapeutic utility of immunotherapies

探索肛门鳞状细胞癌的免疫景观和免疫疗法的治疗效用

• 批准号: nhmrc : GNT1133019
• 负责人: Dr Glen Guerra
• 金额: $ 4.88万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/exploring-immune-landscape-utility-immunotherapies/1347866
• 关键词: Exploring; immune; landscape; anal; squamous

Anal cancer has been on the rise without improvements in patient treatment or survival over the last three decades. Immunotherapy which uses a patient's immune system to combat cancer has demonstrated great success in the treatment of several tumours, and consequently demands investigation for patients with anal cancer. This project is focussed on examining the immune system's role in anal cancer, and whether immunotherapies can be used to improved treatment response and patient survival.

在过去的三十年里，肛门癌的发病率一直在上升，但患者的治疗或生存率没有改善。免疫疗法利用患者的免疫系统来对抗癌症，在治疗几种肿瘤方面取得了巨大成功，因此需要对肛门癌患者进行研究。该项目的重点是检查免疫系统在肛门癌中的作用，以及免疫疗法是否可以用于改善治疗反应和患者生存。